Executive summary

This study from Japan evaluated outcomes of PBT for locally recurrent parotid gland cancer. Ten patients were treated to 70.2 Gy equivalents in 32 fractions. With the median follow-up of 24 months, the study reported that the 1-year overall survival and local control rates were 80 %, and the 3-year overall survival and local control rates were 60 %, and no patient experienced grade 3-5 toxicities.

This study concluded that PBT could be applied effectively and safely for patients with locally recurrent parotid gland cancer.
 

Top cancer treatments